πŸŽ€ Special Scenarios in Pharmacovigilance

β€”

by

β€”

This blog features:

  1. A summary of special case scenarios
  2. Importance associated with those scenarios
  3. Instances illustrating special scenarios.

Table of Contents:

  1. Definition
  2. Significance of Unique Scenarios
  3. Special Scenarios: Typical Situations
  4. Key takeaways
  5. Thoughts
  6. References
  7. FAQ

Definition

Special situations aren’t always listed. It may, unconventional and non-standard things can occur sometimes. In many cases, these situations happen because of abnormal conditions or mistakes made by the patient.

It doesn’t necessarily occur because of the effects of the drugs administered.

Significance of Unique Scenarios

You might be curious about the importance and inclusion of special situations in the case file.

πŸ“’ Recommendation: I highly recommending in the refined realm of blogs exclusively dedicated category to the intricacies of ICSR case processing.

What makes this report significant?

These reports on special situations are mandatory and can provide valuable information:

  1. Identifying defects in product manufacturing
  2. Adhering to regulatory guidelines
  3. Evaluating the balance between benefits and risks
  4. Investigating causes related to pregnancy
  5. Meeting specific requirements outlined in the protocol.

✍️ Note: The situations like overdose, off-label use, and drug misuse, where there are no suspected harmful effects and no need to report as individual case safety reports, it’s still important to gather and include this information in regular safety reports. This helps experts analyze the overall periodic safety reports of the medicine and evaluate its benefits versus risks.

Special Scenarios: Typical Situations

  1. Overdose & Under-dose
  2. Medication error(s)
  3. Off-label use
  4. Drug interactions
  5. Drug abuse
  6. Drug misuse
  7. Lack of efficacy
  8. Pregnancy and Lactation
  9. Counterfeit or falsified medicines
  10. Death
  11. Suspected transmission of infectious agents via a medicinal product (STIAMP)
  12. Addiction or Dependency
  13. Disease progression
  14. Use of a medicinal product in a pediatric or elderly population
  15. Occupational exposure
  16. Drug taken beyond expiry date (common scenario)

“Special events are not just moments in time; they are the chapters that write the unique story of our lives, weaving memories that sparkle with the magic of extraordinary moments.”

1. Overdose & Under-dose

These scenarios are commonplace in pharmacovigilance case processing.

Overdose:

Overdose occurs when more than the prescribed or authorized amount of a substance is administered, surpassing the recommended quantity.

Under-dose:

Under-dose happens when a patient receives or is prescribed less than the recommended amount.

πŸ“’ I suggest checking our article that defines overdose and under-dose as adverse events, providing coding conventions as illustrative examples.

2. Medication error(s)

It is an accidental mistake that occurs during treatment, causing harm or discomfort to the patient. These errors stem from human mistakes and can happen at various stages of the treatment process, such as during the creation of written prescriptions, dispensing, storage, and administration.

3. Off-label use

This is the condition where the drug is intentionally or unintentionally used for out of focus (unintended) for the particular indication authorised by regulatory bodies. Simply we can say in other words as not administered for recommended.

  • Intentional off-label use
  • Unintentional off-label use

πŸ“’ Follow this link for an in-depth exploration of off-label drug use, including how it’s considered in case processing and coding within pharmacovigilance.

4. Drug interactions

Drug interactions occur when drugs interact with each other or with any other consumable products like foods and beverages, potentially affecting the body’s enzymes, hormones, or pre-existing medical conditions.

Such interactions may lead to various reactions, often triggered by discomfort within the body.

πŸ“’ Click here to learn more about managing cases containing drug interactions as adverse events in detail.

5. Drug abuse

Drug abuse involves the excessive and inappropriate use of drugs, deviating from labeled or prescribed advice.

This behavior can take different forms, including the overuse of prescription medications and the recreational use of illicit substances. Such inadvisable actions may result in addiction or dependency.

6. Drug misuse

Drug misuse refers to the inappropriate or improper use of drugs, including both prescription and over-the-counter medications.

Unlike drug abuse, which often implies a more severe and harmful pattern of use, drug misuse encompasses a broader range of behaviors that deviate from the intended or recommended use of a drug. Drug misuse can include:

  • Taking Medications Without Prescription
  • Not Following Prescription Instructions
  • Using Medications for Non-Medical Purposes
  • Mixing Medications Inappropriately
  • Using Over-the-Counter Drugs Inappropriately

While drug misuse may not always lead to severe consequences like addiction, it still poses risks to an individual’s health and well-being.

It’s essential for individuals to use medications only as prescribed or directed by healthcare professionals and to seek guidance if they have concerns or questions about their medications.

7. Lack of efficacy

Lack of efficacy” refers to a situation where a patient encounters an inadequate response that falls short of the promised efficiency. In simpler terms, it means that the effectiveness or desired outcome is below the expected level based on the prescribed product.

πŸ“’ Dive deeper into understanding how to manage cases of lack of efficacy during case processing and learn the assessment methods.

8. Pregnancy and Lactation

Pregnancy is a natural occurrence in the course of living life. However, in the context of adverse event monitoring, it becomes a crucial and noteworthy factor. Potential adverse events are more likely to occur through the placental barrier transmission and during lactation.

It is imperative to approach this matter with great concern, ensuring vigilant monitoring and diligent reporting.

9. Counterfeit or falsified medicines

Counterfeit medicines, falsely presented as authentic, can pose serious health risks. They may contain incorrect ingredients, inadequate or excessive doses, or even harmful substances. Reporting such instances is crucial due to the abnormal nature of these occurrences.

  • Contain substances of lower quality or the wrong dose
  • Be deliberately and fraudulently mislabelled with the intention to avoid identifying the source
  • Have counterfeit packaging, wrong ingredients or a lower proportion of the active substance

πŸ“’ Explore further details on managing adverse events related to counterfeit medicines in pharmacovigilance by clicking here.

10. Death

Death, although a natural occurrence like pregnancy, is still treated as a special scenario. Continuous monitoring is essential until it is confirmed that the cause of death is not linked to the administered drug.

Therefore, such cases need to be followed even after the individual has passed away.

11. Suspected transmission of infectious agents via a medicinal product (STIAMP)

It might be associated with product complaints, but beyond such complaints, it becomes a special scenario. Any organism, including viruses or infectious particles like prion proteins associated with spongiform encephalopathy, whether pathogenic or nonpathogenic, is regarded as an infectious agent.

The transmission of these agents can be identified through clinical symptoms and laboratory findings.

12. Addiction or Dependency

It is not a disease but may be regarded as a disorder, specifically a psychotic disorder or a mood-related behavior. Examples of scenarios include:

  1. Dependency on certain legal or illegal drugs or specific medications, hindering progress to the next step without administration.
  2. Mood impairment or alteration that occurs in the absence of the drug.

13. Disease progression

The occurrence of exacerbation and progression in an atypical or pre-existing condition or diagnosed disease is observed, especially in treatment with certain medication.

14. Use of a medicinal product in a paediatric or elderly population

The intentional or unintentional use of drugs in an inadvisable manner, including the use of doses not recommended for specific genders or age groups, can occur. In some cases, drugs may be utilized inappropriately in the wrong population, such as using inadvisable doses in the pediatric population.

15. Occupational exposure

Occupational exposure refers to the situation where individuals are subjected to medicinal agents while performing specific job roles, leading to adverse reactions.

Key takeaways

  • Special case scenarios usually aren’t directly caused by drugs, hence they’re termed as special events.
  • However, they can still have an impact and potentially lead to adverse events.
  • EMA and FDA deem reported few special event scenarios as invalid unless accompanied by additional events (off-label use, Medication errors, Overdose and so on).
  • Despite this, including scenario data in PSURs remains crucial for addressing safety concerns.
  • If special scenarios are spontaneously reported, causality should be suspected.

Wrap up

Thus, you can gain insights into the various special scenarios in pharmacovigilance by understanding the nuances.

Each scenario is explained simply and comprehensively. If there are any essential scenarios I might have overlooked,

Feel free to comment and add your insights.”

References:
  1. EMA Guide
  2. FDA Guide
FAQ:

What does it mean by special situations in the field of pharmacovigilance?

A special situation in pharmacovigilance is an occurrence distinct from listed adverse events associated with a product. Non-standard events may transpire, occasionally unrelated to drugs.

What is the importance of these distinctive scenarios?

1. Identifying defects
2. Evaluating the balance between benefits and risks
3. Investigating causes
4. Adhering to regulatory guidelines

What are some examples of specific special scenarios in pharmacovigilance cases?

1. Overdose
2. Medication error(s)
3. Off-label use
4. Drug interactions
5. Drug abuse & many more

Disclaimer: We write this blog based on our experience and extensive knowledge, supported by references. Please note that we are not responsible for the content on the referenced websites. If you come across any misinformation or misguidance or spelling mistakes, kindly inform us promptly.



Bala Avatar

Meet Bala, the founder of Drugvigil, a service provider specializing in pharmacovigilance. He’s not only an expert in this field, but also a passionate entrepreneur who enjoys creating new opportunities and helping others grow. Despite starting from scratch, he’s determined to develop his company from the ground up. If you’re interested in his work, be sure to show your support and share his message with others.




Just a fancy image. www.drugvigil.com






Comments

2 responses to “πŸŽ€ Special Scenarios in Pharmacovigilance”

  1. […] πŸŽ‡ Recommendation: Here, I recommend an article that specifically discusses the special scenarios in pharmacovigilance. […]

  2. […] Recommendations: I highly suggest delving into our current blog, where we extensively cover various special case scenarios within pharmacovigilance. If you’re specifically interested in exploring individual adverse events, we can focus on […]

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.